🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Healthcare stocks dip on potential PBM legislation

Published 12/12/2024, 02:20 AM
© Reuters.
CI
-
CVS
-
UNH
-

Shares of prominent US healthcare companies fell Wednesday amid news of potential legislation targeting pharmacy benefit managers (PBMs).

The proposed bill, which lawmakers are currently drafting, aims to compel PBMs to sell off the pharmacies they own.

This move represents a significant intervention in the operational model of PBMs, which act as intermediaries in the drug prescription process.

UnitedHealth Group (NYSE:UNH) saw its shares decrease by up to 5.6%, while both Cigna (NYSE:CI) and CVS Health (NYSE:CVS) witnessed declines of up to 5.3%.

The S&P 500 Managed Care Index also felt the impact, falling up to 4.7%, marking its lowest point since June.

According to Leerink Partners, the likelihood of the bill's passage is low, but it is noted as the most aggressive measure proposed to date against the PBM industry.

Elizabeth Anderson from Evercore ISI commented on the situation, observing that this legislative effort is the latest in a series of government actions aimed at increasing regulation of PBMs.

This focus is partly due to the growing financial strain on patients and the fact that purchasing prescription drugs is a common aspect of voter interaction with their healthcare coverage.

Anderson highlighted the bipartisan nature of the initiative as incremental but assessed its chance of passing as slim, particularly as Congress is nearing the end of its current session.

She mentioned that while the bill poses headline risk at present, there might be a higher probability of such legislation passing in 2025, although still below a 50% likelihood.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.